Vairavan Latha 4
4 · Arcutis Biotherapeutics, Inc. · Filed Nov 5, 2025
Insider Transaction Report
Form 4
Vairavan Latha
SVP Chief Financial Officer
Transactions
- Sale
Common Stock
2025-11-03$24.72/sh−88$2,175→ 64,927 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.435 to $25.31, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.